Activists In South Africa Demand Country Update Patent Laws To Help Improve Access To Medicines

Quartz: South Africa’s outdated patent laws are standing in the way of affordable, lifesaving drugs
“…Protests in Pretoria on Sept. 27 sought to highlight the exorbitant prices of many lifesaving drugs in the country. [The group of activists behind the Fix the Patent Law campaign] lay the blame on medical patent laws that allow drug companies to charge full price for medication that can be purchased for much less in other parts of the world. The hepatitis B treatment, for instance, costs about $400 in South Africa, compared to just $35 in India…” (Chutel, 9/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.